These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38627123)

  • 21. Prevalence of latent tuberculosis infection among participants of the national LTBI screening program in South Korea - A problem of low coverage rate with current LTBI strategy.
    Kim HW; Min J; Choi JY; Shin AY; Myong JP; Lee Y; Yim HW; Jeong H; Bae S; Choi H; In H; Park A; Jang M; Koo HK; Lee SS; Park JS; Kim JS
    Front Public Health; 2022; 10():1066269. PubMed ID: 36743163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity.
    Mirzazadeh A; Kahn JG; Haddad MB; Hill AN; Marks SM; Readhead A; Barry PM; Flood J; Mermin JH; Shete PB
    PLoS One; 2021; 16(4):e0249012. PubMed ID: 33793612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of developing tuberculosis following tumor necrosis factor inhibition and interleukin-6 inhibition in patients with rheumatoid arthritis: a nationwide observational study in South Korea, 2013-2018.
    Jung SM; Han M; Kim EH; Jung I; Park YB
    Arthritis Res Ther; 2022 Jun; 24(1):157. PubMed ID: 35761359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with refusal of preventive therapy after initial willingness to accept treatment among college students with latent tuberculosis infection in Shandong, China.
    Yuan Y; Jin J; Bi X; Geng H; Li S; Zhou C
    BMC Infect Dis; 2023 Jan; 23(1):38. PubMed ID: 36670356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.
    Dorjee K; Topgyal S; Tsewang T; Tsundue T; Namdon T; Bonomo E; Kensler C; Lhadon D; Choetso T; Nangsel T; Dolkar T; Tsekyi T; Dorjee C; Phunkyi D; Sadutshang TD; Paster Z; Chaisson RE
    PLoS Med; 2021 Jan; 18(1):e1003502. PubMed ID: 33465063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
    Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
    Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis incidence in country of origin is a key determinant of the risk of active tuberculosis in people living with HIV: Data from a 30-year observational cohort study.
    White HA; Okhai H; Kirwan P; Rafeeq SH; Dillon H; Hefford P; Wiselka MJ; Pareek M
    HIV Med; 2022 Jul; 23(6):650-660. PubMed ID: 34939299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence and Risk Factors of Active Tuberculosis Among Hospitalized Patients with Latent Tuberculosis Infection in China: A Cohort Study.
    Liu Y; Zhang L; Chen Y; Ruan G; Liu Y; Chen S; Xie L; Wu F; Shi X; Liu X
    Infect Drug Resist; 2024; 17():953-960. PubMed ID: 38495623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of latent and active tuberculosis infection in travellers: a systematic review and meta-analysis.
    Diefenbach-Elstob TR; Alabdulkarim B; Deb-Rinker P; Pernica JM; Schwarzer G; Menzies D; Shrier I; Schwartzman K; Greenaway C
    J Travel Med; 2021 Jan; 28(1):. PubMed ID: 33225357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis.
    Jo KW; Hong Y; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2013 Nov; 107(11):1797-802. PubMed ID: 24029000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea.
    Kim HJ; Lee GH; Ryoo S; Oh SY; Lee JB; Kim JH; Shin C; Lee SH
    Int J Tuberc Lung Dis; 2015 May; 19(5):576-81. PubMed ID: 25868027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased annual risk of tuberculosis infection in South Korean healthcare workers using interferon-gamma release assay between 1986 and 2005.
    Lee EH; Son NH; Kwak SH; Choi JS; Kim MC; Seol CH; Kim SR; Park BH; Kang YA
    BMC Infect Dis; 2021 Nov; 21(1):1161. PubMed ID: 34784896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and Risk Factors Associated with Latent Tuberculosis Infection and Pulmonary Tuberculosis among People Deprived of Liberty in Colombian Prisons.
    Herrera M; Keynan Y; López L; Marín D; Arroyave L; Arbeláez MP; Vélez L; Rueda ZV
    Am J Trop Med Hyg; 2021 Dec; 106(1):66-74. PubMed ID: 34872056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of nationwide programmatic testing and treatment for latent tuberculosis infection in migrants in England: a retrospective, population-based cohort study.
    Berrocal-Almanza LC; Harris RJ; Collin SM; Muzyamba MC; Conroy OD; Mirza A; O'Connell AM; Altass L; Anderson SR; Thomas HL; Campbell C; Zenner D; Phin N; Kon OM; Smith EG; Lalvani A
    Lancet Public Health; 2022 Apr; 7(4):e305-e315. PubMed ID: 35338849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association between Circulating microRNAs and the Risk of Active Disease Development from Latent Tuberculosis Infection: a Nested Case-Control Study.
    Xin H; Cao X; Du Y; Yan J; He R; Liu Z; Zhang H; He Y; Zhang B; Wang D; Guan L; Shen F; Feng B; Quan Z; He Y; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Jun; 10(3):e0262521. PubMed ID: 35435753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registry.
    Sánchez-Moya AI; García-Doval I; Carretero G; Sánchez-Carazo J; Ferrandiz C; Herrera Ceballos E; Alsina M; Ferrán M; López-Estebaranz JL; Gómez-García F; De la Cueva Dobao P; Carrascosa JM; Vanaclocha F; Belinchón I; Peral F; Dauden E;
    J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1366-74. PubMed ID: 23134268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
    Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
    J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.
    Ronald LA; Campbell JR; Rose C; Balshaw R; Romanowski K; Roth DZ; Marra F; Schwartzman K; Cook VJ; Johnston JC
    Clin Infect Dis; 2019 Nov; 69(12):2101-2108. PubMed ID: 30856258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and prognosis for latent tuberculosis infection in dialysis patients: A retrospective cohort study at a single tertiary care center.
    Xia Y; Fan Q; Zhang J; Jiang L; Huang X; Xiong Z; Xiong Z
    Semin Dial; 2024; 37(1):59-64. PubMed ID: 36823755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Latent tuberculosis infection: recent progress and challenges in South Korea.
    Jeon D
    Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.